(CNN) — Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people on a similar competitor, Ozempic, ...

U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss ...

Abbott Laboratories and WeightWatchers have partnered to give people living with diabetes more insight into their condition. The initiative integrates WeightWatchers’ diabetes-specific weight ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

(CNN) — Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs, ...

The focus of obesity-management interventions should shift from percentage weight-loss targets to patient-oriented parameters such as enhancing quality of life (QoL) and function, research to be ...

Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...

If you're starting 2019 with the goal of getting healthier, let us help. Check out all our earnings call transcripts. If January is the month of good intentions, then February is the month of letting ...